A Simplified Scintillation Proximity Assay for Fatty Acid Synthase Activity: Development and Comparison with Other FAS Activity Assays

被引:16
作者
Bays, Nathan W. [1 ]
Hill, Armetta D. [1 ]
Kariv, Ilona [1 ]
机构
[1] Merck Res Labs, Dept In Vitro Sci, Boston, MA 02115 USA
关键词
fatty acid synthase; FAS; lipogenesis; scintillation proximity assay; SPA; INHIBITORS; BIOSYNTHESIS; COENZYME;
D O I
10.1177/1087057109335746
中图分类号
Q5 [生物化学];
学科分类号
070307 [化学生物学];
摘要
Fatty acid synthase (FAS), an essential enzyme for de novo lipogenesis, has been implicated in a number of disease states, including obesity, dyslipidemia, and cancer. to identify small-molecule inhibitors of FAS, the authors developed a bead-based scintillation proximity assay (SPA) to detect the fatty acid products of FAS enzymatic activity. this homogeneous SPA assay discriminates between a radiolabeled hydrophilic substrate of FAS (acetyl-coenzyme A) and the labeled lipophilic products of FAS (fatty acids), generating signal only when labeled fatty acids are present. the assay requires a single addition of unmodified polystyrene imaging SPA beads and can be miniaturized to 384- or 1536-well density with appropriate assay statistics for high-throughput screening. high-potency FAS inhibitors were used to compare the sensitivity of the SPA bead assay with previously described assays that measure FAS reaction intermediates (coa-SH and NADP(+)). the advantages and disadvantages of these different FAS assays in small-molecule inhibitor discovery are discussed. (Journal of Biomolecular Screening 2009:636-642)
引用
收藏
页码:636 / 642
页数:7
相关论文
共 14 条
[1]
A fluorescence-based thiol quantification assay for ultra-high-throughput screening for inhibitors of coenzyme A production [J].
Chung, Christine C. ;
Ohwaki, Kenji ;
Schneeweis, Jonathan E. ;
Stec, Erica ;
Varnerin, Jeffrey P. ;
Goudreau, Paul N. ;
Chang, Amy ;
Cassaday, Jason ;
Yang, Lihu ;
Yamakawa, Takeru ;
Kornienko, Oleg ;
Hodder, Peter ;
Inglese, James ;
Ferrer, Marc ;
Strulovici, Berta ;
Kusunoki, Jun ;
Tota, Michael R. ;
Takagi, Toshimitsu .
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2008, 6 (03) :361-374
[2]
Thermogenic and metabolic antiobesity drugs: rationale and opportunities [J].
Clapham, J. C. ;
Arch, J. R. S. .
DIABETES OBESITY & METABOLISM, 2007, 9 (03) :259-275
[3]
STEADY-STATE KINETIC-STUDY OF FATTY-ACID SYNTHASE FROM CHICKEN LIVER [J].
COX, BG ;
HAMMES, GG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (14) :4233-4237
[4]
Fatty acid synthase inhibitors: new directions for oncology [J].
Kridel, Steven J. ;
Lowther, W. Todd ;
Pemble, Charles W. .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (11) :1817-1829
[5]
A high-throughput two-phase partition assay to measure the activity of lipid-metabolizing enzymes [J].
Kristie, James ;
Toth, Joshuaine G. ;
Silverstrim, Christine ;
Pickett, Walter ;
Landro, James A. .
ANALYTICAL BIOCHEMISTRY, 2006, 358 (02) :266-272
[6]
The crystal structure of yeast fatty acid synthase, a cellular machine with eight active sites working together [J].
Lomakin, Ivan B. ;
Xiong, Yong ;
Steitz, Thomas A. .
CELL, 2007, 129 (02) :319-332
[7]
MACHIDA M, 1977, CHEM PHARM BULL, V25, P1289
[8]
Architecture of mammalian fatty acid synthase at 4.5 Å resolution [J].
Maier, T ;
Jenni, S ;
Ban, N .
SCIENCE, 2006, 311 (5765) :1258-1262
[9]
MECHANISM AND CONTROL OF MALONYL-COA-DEPENDENT CHAIN ELONGATION OF FATTY-ACIDS - MALONYL-TRANSFER REACTION [J].
PODACK, ER ;
SAATHOFF, G ;
SEUBERT, W .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1974, 50 (01) :237-243
[10]
3-aryl-4-hydroxyquinolin-2(1H)-one derivatives as type I fatty acid synthase inhibitors [J].
Rivkin, Alexey ;
Kim, Yoona R. ;
Goulet, Mark T. ;
Bays, Nathan ;
Hill, Armetta D. ;
Kariv, Ilona ;
Krauss, Stefan ;
Ginanni, Nicole ;
Strack, Peter R. ;
Kohl, Nancy E. ;
Chung, Christine C. ;
Varnerin, Jeffrey P. ;
Goudreau, Paul N. ;
Chang, Amy ;
Tota, Michael R. ;
Munoz, Benito .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (17) :4620-4623